Leigh syndrome – where are those mitochondria replacement therapies?

Dear Sir: I came across your blog after reading Stanley Bing’s recent article in Fortune Magazine. I will try to be brief. I have a 4 year old son who was diagnosed 1.5 years ago with a form of Leigh’s disease; one of the most devastating forms of mitochondrial disease. While he is receiving care… Continue reading Leigh syndrome – where are those mitochondria replacement therapies?

Off-the-shelf skin replacements are on their way…

UK scientists in artificial skin breakthrough: “A long-lasting artificial skin has been developed by British researchers. The Cambridge-based Intercytex Group Plc has announced that tests had produced promising results in healing wounds in early clinical trials…. ICX-SKN is created from a matrix produced by the same skin cells that are responsible for synthesising new tissue… Continue reading Off-the-shelf skin replacements are on their way…

Redifferentiating brain tumour stem cells: the concept of cancer regenerative medicine

The trendy cancer stem cell theory highlights that there is a functional hierarchy between different tumour cells and only a small portion, the so called cancer stem cells have crucial role in initiating tumour growth. This assumption was confirmed in the case of blood, breast and brain for example. Based on that a new therapeutic… Continue reading Redifferentiating brain tumour stem cells: the concept of cancer regenerative medicine

Questions to contra life extensionists: rational pitfalls

Critical thinking is crucial to every successful scientific and technological project. In order to consider any attempt to the extension of life in details,we have to take a look at the other side of the coin. So in the future I try to blogterview some experts, scholars, philosophers, activists, …who are opposing some concrete points… Continue reading Questions to contra life extensionists: rational pitfalls

FDA Stem Cell Therapy Regulation: the Framework

Dina Gould Halme and David A. Kessler wrote an article, called FDA Regulation of Stem-Cell–Based Therapies in The New England Journal of Medicine. The key concerns are: i., Stem-cell–based products as therapeutic agents are or could be: biologic products, drugs, devices, xenotransplantation products, human cells, tissues, and cellular and tissue-based products. Human cells, tissues, and… Continue reading FDA Stem Cell Therapy Regulation: the Framework

Bodies in the Making book, essays by UC Santa Cruz professors

A new book coedited by UC Santa Cruz Literature and Anthropology professors Helene Moglen and Nancy Chen, Bodies in the Making: Transgressions and Transformations, explores a range of practices that aren’t usually linked: tattooing, cosmetic surgery, body-building, life extension technologies, self-cutting. The common denominator is intended to be body hacking, modification and our fascination with… Continue reading Bodies in the Making book, essays by UC Santa Cruz professors